A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG

Verfasser: Smorenburg, C.H.
de Groot, S.M.
van Leeuwen-Stok, A.E.
Hamaker, M.E.
Wymenga, A.N.
de Graaf, H.
de Jongh, F.E.
Braun, J.J.
Los, M.
Maartense, E.
van Tinteren, H.
Nortier, J.W.R.
Seynaeve, C.
Dokumenttyp: Artikel
Erscheinungsdatum: 2014
Reihe/Periodikum: Annals of Oncology ; volume 25, issue 3, page 599-605 ; ISSN 0923-7534
Verlag/Hrsg.: Elsevier BV
Schlagwörter: Oncology / Hematology
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27028434
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://dx.doi.org/10.1093/annonc/mdt588